Royal Philips announces the launch of the U.S. FDA 510(k)-cleared QuickClear mechanical thrombectomy system, which provides an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems. Moreover, the system’s all-in-one design eliminates the need for capital equipment or costly accessories, with easy setup supporting faster procedures times. 

“This novel thrombectomy system is the latest addition to Philips’ market-leading portfolio for the diagnosis and treatment of peripheral vascular diseases,” says Chris Landon, senior vice president and general manager of image-guided therapy devices at Philips. “Its intuitive design simplifies the entire thrombectomy procedure workflow. By taking away the high initial capital expenditure costs associated with traditional mechanical thrombectomy systems, QuickClear can help bring cost-effective solutions to both the hospital and outpatient care settings.”

Further, the small footprint of the sterile device allows it to be placed conveniently on the table next to the patient. With the touch of a button, the system is up and running at maximum aspiration power within seconds. Also, the consistency of the aspiration power during the procedure provides physicians more control and supports faster procedure times. The system’s range of catheters includes a large 10F aspiration catheter, providing 59% more aspiration volume than 8F 

“The system is significantly smaller than other systems without compromising aspiration power,” says Bryan Fisher, MD, chief of vascular surgery at Tristar Centennial Medical Center in Nashville, Tenn. “The convenience of the device really shines through with its single use and lack of capital equipment. I am excited about the potential of this device and the impact it will have on my practice and the patients I treat.”